YouGene is creating the world’s first marketplace where laboratories are financially incentivized to share valuable genetic biomarkers with other stakeholders. Clinicians and insurers have access to a comprehensive database of validated biomarkers, laboratories are compensated for novel contributions, and test developers mitigate regulatory risk by using a regulatory-compliant database. To achieve this, YouGene uses a patent-pending, micro-attribution royalty framework that encourages submission with income payments and trade secret protection. The result is a platform that induces laboratories, clinicians, and insurers to participate.